Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Long-term safety and effectiveness of the Fantom bioresorbable coronary artery scaffold: final results of the FANTOM II trial.

Autor: Lutz M; Department of Cardiology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany., Abizaid A; Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.; Hospital Israelita Albert Einstein, São Paulo, Brazil., Nielsen Holck E; Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark., Lansky A; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA., Carrié D; Department of Cardiology, University Hospital Rangueil, Toulouse, France., Weber-Albers J; St. Johannes Hospital, Dortmund, Germany., Dudek D; Institute of Cardiology, Jagiellonian University Medical College, University Hospital, Krakow, Poland., Frey N; Department of Cardiology, University Hospital Heidelberg, Heidelberg, Germany., Christiansen EH; Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark., Holm NR; Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark., Stone GW; Columbia University Medical Center/NewYork-Presbyterian Hospital, The Cardiovascular Research Foundation, New York, NY, USA.

Publikováno v: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology [EuroIntervention] 2024 Apr 01; Vol. 20 (7), pp. e453-e456. Date of Electronic Publication: 2024 Apr 01.